Skip to main content
. 2012 Jul 17;7:16. doi: 10.1186/1750-9378-7-16

Table 2.

Detection of galectin-9 in liver specimens from infected (HCV, HBV) or non-infected patients

Patient
Gender/Age Medical History
Viral diagnosis
Histological diagnosis
Galectin-9 staining
        Leucocytes or related cells Hepatocytes
1
M/54
Chronic HCV infection
HCV cirrhosis with transformed foci
-
+ +
 
Alcoholism
 
 
 
 
2
M/66
Chronic HCV infection
Micronodular cirrhosis associated to a carcinoma
+ + (aspect of Kupffer cells)
+ +
 
Alcoholism
 
 
 
 
3
M/61
Chronic HCV infection
Micronodular cirrhosis with transformed foci
+
+
4
M/67
Chronic HBV infection
Macronodular cirrhosis associated to a carcinoma
+
+
5
M/50
Chronic HBV infection
Hepatic fibrosis associated to a carcinoma
+ +
+ +
6
M/30
Chronic HBV infection
Liver tissue with minimal lesions next to a non-malignant nodule (focal nodular hyperplasia)
+
+ +
7
F/32
No infection
Normal liver tissue next to a non-malignant nodule (focal nodular hyperplasia)
-
-
8
F/20
No infection
Normal liver tissue next to an adenoma
-
-
9 F/28 No infection Normal liver tissue next to an adenoma (with steatosis) - -

++ : homogeneous galectin-9 staining, + : mild or scattered galectin-9 staining, - : absence of galectin-9 staining.